[
    [
        {
            "time": "",
            "original_text": "东, 方, 基, 因, 收, 入, 9, 5, %, 来, 自, 海, 外, 冲, 刺, 科, 创, 板, 研, 发, 占, 比, 不, 到, 7, %",
            "features": {
                "keywords": [
                    "东方基因",
                    "收入",
                    "海外",
                    "科创板",
                    "研发占比"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物科技",
                    "医疗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive",
                "revenue_source": "overseas",
                "ipo_focus": "STAR Market",
                "research_development_ratio": "low"
            },
            "scores": {
                "News_content": "东, 方, 基, 因, 收, 入, 9, 5, %, 来, 自, 海, 外, 冲, 刺, 科, 创, 板, 研, 发, 占, 比, 不, 到, 7, %",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]